Market Research Logo

North America and Europe Peptide Cancer Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023

North America and Europe Peptide Cancer Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host.

Scope of the Report:
This report focuses on the Peptide Cancer Vaccine in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
TapImmune
BrightPath Biotherapeutics
Ultimovacs
Sellas
Boston Biomedical
Imugene
VAXON Biotech
Generex Biotechnology
ISA Pharmaceuticals
OncoTherapy Science
Immatics

Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain

Market Segment by Type, covers

Market Segment by Applications, can be divided into
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others

There are 19 Chapters to deeply display the North America and Europe Peptide Cancer Vaccine market.

Chapter 1, to describe Peptide Cancer Vaccine Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Peptide Cancer Vaccine, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Peptide Cancer Vaccine, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;

Chapter 14, Peptide Cancer Vaccine market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers, etc.

Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.


1 Market Overview
1.1 Peptide Cancer Vaccine Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Lung Cancer
1.3.3 Melanoma
1.3.4 Prostate Cancer
1.3.5 Others
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 TapImmune
2.1.1 Business Overview
2.1.2 Peptide Cancer Vaccine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 TapImmune Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 BrightPath Biotherapeutics
2.2.1 Business Overview
2.2.2 Peptide Cancer Vaccine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Ultimovacs
2.3.1 Business Overview
2.3.2 Peptide Cancer Vaccine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Ultimovacs Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sellas
2.4.1 Business Overview
2.4.2 Peptide Cancer Vaccine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sellas Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boston Biomedical
2.5.1 Business Overview
2.5.2 Peptide Cancer Vaccine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Boston Biomedical Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Imugene
2.6.1 Business Overview
2.6.2 Peptide Cancer Vaccine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Imugene Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 VAXON Biotech
2.7.1 Business Overview
2.7.2 Peptide Cancer Vaccine Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 VAXON Biotech Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Generex Biotechnology
2.8.1 Business Overview
2.8.2 Peptide Cancer Vaccine Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Generex Biotechnology Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 ISA Pharmaceuticals
2.9.1 Business Overview
2.9.2 Peptide Cancer Vaccine Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 OncoTherapy Science
2.10.1 Business Overview
2.10.2 Peptide Cancer Vaccine Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 OncoTherapy Science Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Immatics
2.11.1 Business Overview
2.11.2 Peptide Cancer Vaccine Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Immatics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Peptide Cancer Vaccine Market Competition, by Manufacturer
3.1 North America and Europe Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Peptide Cancer Vaccine Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Peptide Cancer Vaccine Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Peptide Cancer Vaccine Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Peptide Cancer Vaccine Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Peptide Cancer Vaccine Market Analysis by Countries/Regions
4.1 North America and Europe Peptide Cancer Vaccine Sales Market Share by Countries/Regions
4.2 North America and Europe Peptide Cancer Vaccine Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Peptide Cancer Vaccine Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Peptide Cancer Vaccine Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Peptide Cancer Vaccine Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Peptide Cancer Vaccine Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Peptide Cancer Vaccine by Type
5.1 North America and Europe Peptide Cancer Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Peptide Cancer Vaccine Revenue and Market Share by Type (2013-2018)
6 North America and Europe Market Segmentation Peptide Cancer Vaccine by Application
6.1 North America and Europe Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
6.2 Breast Cancer Sales Growth (2013-2018)
6.3 Lung Cancer Sales Growth (2013-2018)
6.4 Melanoma Sales Growth (2013-2018)
6.5 Prostate Cancer Sales Growth (2013-2018)
6.6 Others Sales Growth (2013-2018)
7 United States Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
7.2.1 United States Peptide Cancer Vaccine Sales by Type (2013-2018)
7.2.2 United States Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
7.3 United States Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018)
7.3.1 United States Peptide Cancer Vaccine Sales by Application (2013-2018)
7.3.2 United States Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
7.4 United States Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Peptide Cancer Vaccine Export and Import (2013-2018)
8 United Kingdom Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Peptide Cancer Vaccine Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Peptide Cancer Vaccine Sales by Type (2013-2018)
8.2.2 United Kingdom Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
8.3 United Kingdom Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Peptide Cancer Vaccine Sales by Application (2013-2018)
8.3.2 United Kingdom Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
8.4 United Kingdom Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Peptide Cancer Vaccine Export and Import (2013-2018)
9 Canada Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
9.2.1 Canada Peptide Cancer Vaccine Sales by Type (2013-2018)
9.2.2 Canada Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
9.3 Canada Sales and Market Share by Application (2013-2018)"
"
9.3.1 Canada Peptide Cancer Vaccine Sales by Application (2013-2018)
9.3.2 Canada Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
9.4 Canada Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Peptide Cancer Vaccine Export and Import (2013-2018)
10 Germany Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
10.2.1 Germany Peptide Cancer Vaccine Sales by Type (2013-2018)
10.2.2 Germany Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
10.3 Germany Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018)
10.3.1 Germany Peptide Cancer Vaccine Sales by Application (2013-2018)
10.3.2 Germany Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
10.4 Germany Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Peptide Cancer Vaccine Export and Import (2013-2018)
11 France Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
11.1 France Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
11.2 France Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
11.2.1 France Peptide Cancer Vaccine Sales by Type (2013-2018)
11.2.2 France Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
11.3 France Sales by Application (2013-2018)"
"
11.3.1 France Peptide Cancer Vaccine Sales by Application (2013-2018)
11.3.2 France Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
11.4 France Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Peptide Cancer Vaccine Revenue and Market Share by Manufacturer
11.5 France Peptide Cancer Vaccine Export and Import (2013-2018)
12 Italy Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
12.2.1 Italy Peptide Cancer Vaccine Sales by Type (2013-2018)
12.2.2 Italy Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
12.3 Italy Peptide Cancer Vaccine Sales and Market Share by Application (2013-2018)
12.3.1 Italy Peptide Cancer Vaccine Sales by Application (2013-2018)
12.3.2 Italy Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
12.4 Italy Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Peptide Cancer Vaccine Export and Import (2013-2018)
13 Spain Peptide Cancer Vaccine Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Peptide Cancer Vaccine Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Peptide Cancer Vaccine Sales and Market Share by Type (2013-2018)
13.2.1 Spain Peptide Cancer Vaccine Sales by Type (2013-2018)
13.2.2 Spain Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
13.3 Spain Peptide Cancer Vaccine Sales by Application (2013-2018)
13.3.1 Spain Peptide Cancer Vaccine Sales by Application (2013-2018)
13.3.2 Spain Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
13.4 Spain Peptide Cancer Vaccine Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Peptide Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Peptide Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Peptide Cancer Vaccine Export and Import (2013-2018)
14 Peptide Cancer Vaccine Market Forecast (2018-2023)
14.1 North America and Europe Peptide Cancer Vaccine Sales, Revenue and Growth Rate (2018-2023)
14.2 Peptide Cancer Vaccine Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Peptide Cancer Vaccine Sales and Growth Rate Forecast (2018-2023)
14.3 Peptide Cancer Vaccine Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Peptide Cancer Vaccine Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Peptide Cancer Vaccine Market Share Forecast by Type (2018-2023)
14.4 Peptide Cancer Vaccine Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Peptide Cancer Vaccine Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Peptide Cancer Vaccine Market Share Forecast by Application (2018-2023)
15 Peptide Cancer Vaccine Manufacturing Cost Analysis
15.1 Peptide Cancer Vaccine Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Peptide Cancer Vaccine
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Peptide Cancer Vaccine Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Peptide Cancer Vaccine Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
List of Tables and Figures
Figure Peptide Cancer Vaccine Picture
Table Product Specifications of Peptide Cancer Vaccine
Figure North America and Europe Sales Market Share of Peptide Cancer Vaccine by Types in 2017
Table Types of Peptide Cancer Vaccine
Figure North America and Europe Peptide Cancer Vaccine Sales Market Share by Applications in 2017
Table Applications of Peptide Cancer Vaccine
Figure Breast Cancer Picture
Figure Lung Cancer Picture
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Others Picture
Figure United States Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Figure United Kingdom Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Figure Germany Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Figure France Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Figure Italy Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Figure Spain Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2013-2023)
Table TapImmune Basic Information, Manufacturing Base and Competitors
Table TapImmune Peptide Cancer Vaccine Type and Applications
Table TapImmune Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BrightPath Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table BrightPath Biotherapeutics Peptide Cancer Vaccine Type and Applications
Table BrightPath Biotherapeutics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ultimovacs Basic Information, Manufacturing Base and Competitors
Table Ultimovacs Peptide Cancer Vaccine Type and Applications
Table Ultimovacs Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sellas Basic Information, Manufacturing Base and Competitors
Table Sellas Peptide Cancer Vaccine Type and Applications
Table Sellas Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Biomedical Basic Information, Manufacturing Base and Competitors
Table Boston Biomedical Peptide Cancer Vaccine Type and Applications
Table Boston Biomedical Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Imugene Basic Information, Manufacturing Base and Competitors
Table Imugene Peptide Cancer Vaccine Type and Applications
Table Imugene Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table VAXON Biotech Basic Information, Manufacturing Base and Competitors
Table VAXON Biotech Peptide Cancer Vaccine Type and Applications
Table VAXON Biotech Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Generex Biotechnology Basic Information, Manufacturing Base and Competitors
Table Generex Biotechnology Peptide Cancer Vaccine Type and Applications
Table Generex Biotechnology Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ISA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table ISA Pharmaceuticals Peptide Cancer Vaccine Type and Applications
Table ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OncoTherapy Science Basic Information, Manufacturing Base and Competitors
Table OncoTherapy Science Peptide Cancer Vaccine Type and Applications
Table OncoTherapy Science Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Immatics Basic Information, Manufacturing Base and Competitors
Table Immatics Peptide Cancer Vaccine Type and Applications
Table Immatics Peptide Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America and Europe Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure North America and Europe Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure North America and Europe Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table North America and Europe Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Table North America and Europe Peptide Cancer Vaccine Revenue Market Share by Manufacturer (2016-2017)
Figure North America and Europe Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America and Europe Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table North America and Europe Peptide Cancer Vaccine Price by Manufacturers (2016-2017)
Figure Top 3 Peptide Cancer Vaccine Manufacturer Market Share in 2016
Figure Top 3 Peptide Cancer Vaccine Manufacturer Market Share in 2017
Figure Top 5 Peptide Cancer Vaccine Manufacturer Market Share in 2016
Figure Top 5 Peptide Cancer Vaccine Manufacturer Market Share in 2017
Figure North America and Europe Peptide Cancer Vaccine Sales and Growth (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Sales by Countries/Regions (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Sales Market Share by Countries (2013-2018)
Figure North America and Europe Peptide Cancer Vaccine Sales Market Share by Countries in 2013
Figure North America and Europe Peptide Cancer Vaccine Sales Market Share by Countries in 2017
Figure North America and Europe Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Revenue by Countries (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America and Europe Peptide Cancer Vaccine Revenue Market Share by Countries in 2013
Figure North America and Europe Peptide Cancer Vaccine Revenue Market Share by Countries in 2017
Table North America and Europe Peptide Cancer Vaccine Sales by Type (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Sales Share by Type (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Revenue by Type (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Revenue Share by Type (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Sales by Application (2013-2018)
Table North America and Europe Peptide Cancer Vaccine Sales Share by Application (2013-2018)
Figure North America and Europe Breast Cancer Sales Growth (2013-2018)
Figure North America and Europe Lung Cancer Sales Growth (2013-2018)
Figure North America and Europe Melanoma Sales Growth (2013-2018)
Figure North America and Europe Prostate Cancer Sales Growth (2013-2018)
Figure North America and Europe Others Sales Growth (2013-2018)
Figure United States Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure United States Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table United States Peptide Cancer Vaccine Sales by Type (2013-2018)
Table United States Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table United States Peptide Cancer Vaccine Sales by Application (2013-2018)
Table United States Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table United States Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure United States Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure United States Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table United States Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure United States Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure United States Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table United States Peptide Cancer Vaccine Export and Import (2013-2018)
Figure United Kingdom Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure United Kingdom Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table United Kingdom Peptide Cancer Vaccine Sales by Type (2013-2018)
Table United Kingdom Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table United Kingdom Peptide Cancer Vaccine Sales by Application (2013-2018)
Table United Kingdom Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table United Kingdom Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure United Kingdom Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure United Kingdom Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table United Kingdom Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure United Kingdom Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure United Kingdom Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table United Kingdom Peptide Cancer Vaccine Export and Import (2013-2018)
Figure Canada Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure Canada Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table Canada Peptide Cancer Vaccine Sales by Type (2013-2018)
Table Canada Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table Canada Peptide Cancer Vaccine Sales by Application (2013-2018)
Table Canada Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table Canada Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure Canada Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure Canada Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table Canada Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure Canada Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure Canada Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table Canada Peptide Cancer Vaccine Export and Import (2013-2018)
Figure Germany Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure Germany Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table Germany Peptide Cancer Vaccine Sales by Type (2013-2018)
Table Germany Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table Germany Peptide Cancer Vaccine Sales by Application (2013-2018)
Table Germany Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table Germany Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure Germany Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure Germany Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table Germany Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure Germany Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure Germany Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table Germany Peptide Cancer Vaccine Export and Import (2013-2018)
Figure France Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure France Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table France Peptide Cancer Vaccine Sales by Type (2013-2018)
Table France Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table France Peptide Cancer Vaccine Sales by Application (2013-2018)
Table France Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table France Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure France Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure France Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table France Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure France Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure France Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table France Peptide Cancer Vaccine Export and Import (2013-2018)
Figure Italy Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure Italy Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table Italy Peptide Cancer Vaccine Sales by Type (2013-2018)
Table Italy Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table Italy Peptide Cancer Vaccine Sales by Application (2013-2018)
Table Italy Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table Italy Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure Italy Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure Italy Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017
Table Italy Peptide Cancer Vaccine Revenue by Manufacturer (2016-2017)
Figure Italy Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2016
Figure Italy Peptide Cancer Vaccine Revenue Market Share by Manufacturer in 2017
Table Italy Peptide Cancer Vaccine Export and Import (2013-2018)
Figure Spain Peptide Cancer Vaccine Revenue and Growth Rate (2013-2018)
Figure Spain Peptide Cancer Vaccine Sales and Growth Rate (2013-2018)
Table Spain Peptide Cancer Vaccine Sales by Type (2013-2018)
Table Spain Peptide Cancer Vaccine Sales Market Share by Type (2013-2018)
Table Spain Peptide Cancer Vaccine Sales by Application (2013-2018)
Table Spain Peptide Cancer Vaccine Sales Market Share by Application (2013-2018)
Table Spain Peptide Cancer Vaccine Sales by Manufacturer (2016-2017)
Figure Spain Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2016
Figure Spain Peptide Cancer Vaccine Sales Market Share by Manufacturer in 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report